Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yash Jani, Caroline S Jansen, Margo B Gerke & Mehmet Asim Bilen. (2024) Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma. Immunotherapy 16:6, pages 405-426.
Read now
Read now
Articles from other publishers (11)
Ping Tian, Yuanyuan Feng & Ling Tao. (2023)
LINC00460
knockdown sensitizes cervical cancer to cisplatin by downregulating
TGFBI
. Chemical Biology & Drug Design 103:1.
Crossref
Crossref
Sarath Babu Nukala, Jordan Jousma, Gege Yan, Zhenbo Han, Youjeong Kwon, Yoonje Cho, Chuyu Liu, Keith Gagnon, Sandra Pinho, Jalees Rehman, Ning-Yi Shao, Sang-Bing Ong, Won Hee Lee & Sang-Ging Ong. (2023) Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor. Cardiovascular Research 119:10, pages 1997-2013.
Crossref
Crossref
Lin Lin, Xiao-Hui Wu, Jun-Ming Zhu, Shao-Hao Chen, Ye-Hui Chen, Fei Lin, Xue-Yi Xue, Yong Wei, Ning Xu, Qing-Shui Zheng & Xiong-Lin Sun. (2023) A Novel Tumor Mutation Burden Related lncRNA Signature Identified
Prognosis and Tumor Immune Microenvironment Features in Clear Cell
Renal Cell Carcinoma. Combinatorial Chemistry & High Throughput Screening 26:8, pages 1503-1518.
Crossref
Crossref
Zhiliang Xiao, Menglei Zhang, Zhenduo Shi, Guanghui Zang, Qing Liang, Lin Hao, Yang Dong, Kun Pang, Yabin Wang & Conghui Han. (2023) Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network. Journal of Oncology 2023, pages 1-19.
Crossref
Crossref
Jacek Rysz, Tomasz Konecki, Beata Franczyk, Janusz Ławiński & Anna Gluba-Brzózka. (2022) The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma. International Journal of Molecular Sciences 24:1, pages 643.
Crossref
Crossref
Wei Zhang, Han Wang, Wei Wang, Haoqiang Xue, Maolin Qiao, Liying Song, Shuang Wang, Zhaoyu Ren & Zhifang Ma. (2022) A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma. Analytical Cellular Pathology 2022, pages 1-32.
Crossref
Crossref
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, Shayan Fallah, Arezoo Sanaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Shamin Rezaei, Hajar Heidari, Mitra Behroozaghdam, Salman Daneshi, Shokooh Salimimoghadam, Sepideh Mirzaei, Mehrdad Hashemi & Saeed Samarghandian. (2022) LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomedicine & Pharmacotherapy 154, pages 113609.
Crossref
Crossref
Zhenpeng Zhu, Cuijian Zhang, Jinqin Qian, Ninghan Feng, Weijie Zhu, Yang Wang, Yanqing Gong, Xuesong Li, Jian Lin & Liqun Zhou. (2022) Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma. Cancer Cell International 22:1.
Crossref
Crossref
Libin Zhou, Hualong Fang, Fei Guo, Min Yin, Huimin Long & Guobin Weng. (2022)
Computational construction of
TME
‐related
lncRNAs
signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
. Journal of Clinical Laboratory Analysis 36:8.
Crossref
Crossref
Zhongbao Zhou, Zhenpeng Yang, Yuanshan Cui, Shuai Lu, Yongjin Huang, Xuanyan Che, Liqing Yang & Yong Zhang. (2022) Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Frontiers in Genetics 13.
Crossref
Crossref
Tinghao Li, Hang Tong, Junlong Zhu, Zijia Qin, Siwen Yin, Yan Sun, Xudong Liu & Weiyang He. (2022) Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma. Frontiers in Medicine 8.
Crossref
Crossref